Skopos Labs, Inc. Simulations Plus, Inc. Transaction History
Skopos Labs, Inc.
- $813 Million
- Q3 2025
Shares
2 transactions
Others Institutions Holding SLP
# of Institutions
181Shares Held
17.3MCall Options Held
38.3KPut Options Held
27.7K-
Black Rock Inc. New York, NY2.46MShares$42.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.3MShares$22.5 Million0.0% of portfolio
-
Tributary Capital Management, LLC1.14MShares$19.7 Million0.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA974KShares$16.9 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN768KShares$13.3 Million1.39% of portfolio
About Simulations Plus, Inc.
- Ticker SLP
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 20,297,700
- Market Cap $351M
- Description
- Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...